Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.

Jessica T MarkowitzDorothee Oberdhan Anna Ciesluk Alissa RamsSharon B Wigal

Published in: Neuropsychiatric disease and treatment (2020)

We identified symptoms and behavioral impacts from qualitative studies in pediatric ADHD that are not included in DSM-based criteria. Most COAs used in pediatric ADHD clinical trials measure only those symptoms listed in the DSM. While these COAs can measure symptom severity, they may not assess the full range of symptoms and impacts important to patients and their caregivers. Future research is needed to measure all concepts important to patients and caregivers within ADHD clinical trials.

Keyphrases

attention deficit hyperactivity disorder
autism spectrum disorder
clinical trial
end stage renal disease
working memory
ejection fraction
palliative care
peritoneal dialysis
randomized controlled trial
sleep quality
patient reported outcomes
open label
phase iii